Eloxx cuts staff, CEO and shakes up leadership team

As Eloxx Pharmaceuticals looks to posts full data from its midstage cystic fibrosis test in the coming months, it has swung the ax on its staffers and hired a new chief executive.

All told, 13 staffers will be axed to help save cash for the biotech until next year. It didn’t specify where all the cuts were from but did say it would “reduce managerial layers and consolidate roles across the organization.” Most are from the biotech’s leadership team.